欧洲生物加工市场预测至 2031 年 - 区域分析 - 按产品（仪器和消耗品及配件）、运营规模（商业运营和临床运营）、工艺（下游生物工艺和上游生物工艺）、应用（单克隆抗体、疫苗、重组蛋白、细胞和基因治疗等）和最终用户（生物制药公司、合同制造组织等）
不断增长的生物制药行业推动欧洲生物加工市场
在生物制药行业，总是需要改进的生物工艺来满足新的监管要求、质量控制要求以及生物制品、细胞培养滴定和生物仿制药生产中的生产问题。近年来，生物制药行业以前所未有的速度增长。生物制药公司在研发上投入巨额资金，以引进具有增强医疗和商业效力的新分子，用于各种治疗应用。由于生物加工在生物制剂和生物仿制药的研究、开发和制造中的广泛应用，其接受度正在逐渐提高。大型制药公司和合同研究组织正在研发新的药物和治疗形式，以治疗各种疾病。此外，对治疗慢性疾病的生物制剂和生物仿制药的强烈需求反过来又推动了生物制药行业的增长。生物制药行业是经济最重要的贡献者之一。生物制剂审批增加、生物仿制药渠道不断扩大、研究活动投资增加以及对开发负担得起的生物制剂的关注度不断提高等因素正在促进生物制药行业的增长。
除此之外，基因和细胞疗法审批的增加也有利于生物加工市场的增长。获批的基因疗法有 Glybera（用于治疗脂蛋白脂肪酶缺乏症）和 Strimvelis（用于治疗 ADA 重度联合免疫缺陷症）。因此，上述因素增加了对各种治疗剂大规模生产的需求，从而促进了生物加工市场的增长。
欧洲生物加工市场概览
生物仿制药引入了竞争并提高了生物制剂的可负担性，最终带来了节约和增值服务，以支持患者护理和医疗保健行业。医疗保健专业人员可以以更低的成本用高质量的生物制剂治疗更多患者。由于巨大的成本节约潜力，德国卫生部出台了一项新法律，以增加生物仿制药的采用。此外，国际参与者之间越来越多的合作也推动了该国市场的增长。例如，2020 年 11 月，日立化学先进治疗解决方案有限责任公司和 apceth Biopharma GmbH 扩大了与 Bluebird Bio 的合作关系，签订了长期开发和制造服务协议，用于多种疗法的临床和商业供应，并扩大了欧洲 ZYNTEGLO 的商业药品制造能力，ZYNTEGLO 是一种用于输血依赖性 α-地中海贫血 (TDT) 的一次性基因疗法。此外，由于拥有众多生物技术公司、高科技研究实验室和大量研发资金，德国的生物技术行业表现出巨大的增长。生物制药和生物制剂研发的增长主要受到医疗保健行业公司采用各种有机战略的推动。例如，2021 年 6 月，Rentschler Biopharma 扩大了其生产能力，增加了 2,000 升的生物反应器，以满足对复杂抗体日益增长的需求，复杂抗体是一类具有持续高潜力的生物制药药物。同样，2023 年 8 月，生物制药行业领先供应商之一 Sartorius 与全球技术和软件领导者 Emerson 合作，将 Sartorius 的 Biostat STR Generation 3 系列生物反应器与 Emerson 的 DeltaVTM 分布式控制系统 (DCS) 集成在一起。因此，由于生物制药公司增加研发支出，该国的生物制药行业正在增长。因此，该国生物制药和生物技术公司的合作研究努力影响着市场。
欧洲生物加工市场收入及预测至 2031 年（百万美元）
欧洲生物加工市场细分
欧洲生物加工市场分为产品、运营规模、流程、应用、最终用户和国家。
根据产品，欧洲生物加工市场分为仪器和消耗品及配件。仪器部门在 2023 年占据了更大的市场份额。此外，仪器部门细分为过滤设备、生物反应器、色谱系统、离心机、干燥设备等。此外，生物反应器子部分分为中试规模、全规模和实验室规模。此外，色谱系统子部分细分为液相色谱、气相色谱等。此外，消耗品及配件部分细分为试剂、细胞培养基、色谱树脂等。
就运营规模而言，欧洲生物加工市场分为商业运营和临床运营。商业运营部门在 2023 年占据了更大的市场份额。
按流程划分，欧洲生物加工市场分为下游生物加工和上游生物加工。下游生物加工部门在 2023 年占据了更大的市场份额。
根据应用，欧洲生物加工市场分为单克隆抗体、疫苗、重组蛋白、细胞和基因治疗等。单克隆抗体部门在 2023 年占据了最大的市场份额。
就最终用户而言，欧洲生物加工市场分为生物制药公司、合同制造组织和其他。生物制药公司部门在 2023 年占据了最大的市场份额。
按国家/地区划分，欧洲生物加工市场分为德国、法国、意大利、英国、西班牙和欧洲其他地区。 2023 年，德国占据了欧洲生物加工市场的主导地位。
Getinge AB、Thermo Fisher Scientific Inc、Sartorius AG、Corning Inc、Bio-Rad Laboratories Inc、Merck KGaA、3M Co、Eppendorf SE、Repligen Corp、Entegris Inc、Agilent Technologies Inc 和 Cytiva US LLC 是欧洲生物加工市场的一些领先公司。
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Bioprocessing Market Landscape
4.1 Ecosystem Analysis
4.1.1 List of Vendors in the Value Chain
5. Europe Bioprocessing Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Chronic Diseases
5.1.2 Growing Biopharmaceutical Industry
5.2 Market Restraints
5.2.1 Stringent Regulatory Policies and Limitations Associated with Bioprocessing
5.3 Market Opportunities
5.3.1 Proliferating Demand for Personalized Medicine
5.4 Future Trends
5.4.1 Shift Toward Automated Cell Therapy Manufacturing
5.5 Impact of Drivers and Restraints:
6. Bioprocessing Market - Europe Analysis
6.1 Europe Bioprocessing Market Overview
6.2 Bioprocessing Market Revenue (US$ Million), 2021-2031
7. Europe Bioprocessing Market Analysis - by Product
7.1 Overview
7.2 Instruments
7.2.1 Overview
7.2.2 Instruments: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
7.2.2.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Instruments
7.2.2.1.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Bioreactors
7.2.2.1.2 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Chromatography Systems
7.3 Consumables & Accessories
7.3.1 Overview
7.3.2 Consumables & Accessories: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
7.3.2.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Consumables & Accessories
8. Europe Bioprocessing Market Analysis - by Scale of Operation
8.1 Overview
8.2 Commercial Operations
8.2.1 Overview
8.2.2 Commercial Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Clinical Operations
8.3.1 Overview
8.3.2 Clinical Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
9. Europe Bioprocessing Market Analysis - by Process
9.1 Overview
9.2 Downstream Bioprocess
9.2.1 Overview
9.2.2 Downstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Upstream Bioprocess
9.3.1 Overview
9.3.2 Upstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10. Europe Bioprocessing Market Analysis - by Application
10.1 Overview
10.2 Monoclonal Antibodies
10.2.1 Overview
10.2.2 Monoclonal Antibodies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.3 Vaccines
10.3.1 Overview
10.3.2 Vaccines: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.4 Recombinant Protein
10.4.1 Overview
10.4.2 Recombinant Protein: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.5 Cell & Gene Therapy
10.5.1 Overview
10.5.2 Cell & Gene Therapy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11. Europe Bioprocessing Market Analysis - by End User
11.1 Overview
11.2 Biopharmaceutical Companies
11.2.1 Overview
11.2.2 Biopharmaceutical Companies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.3 Contract Manufacturing Organization
11.3.1 Overview
11.3.2 Contract Manufacturing Organization: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.4 Others
11.4.1 Overview
11.4.2 Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12. Europe Bioprocessing Market - Country Analysis
12.1 Europe
12.1.1 Europe: Bioprocessing Market Breakdown, by Key Countries, 2023 and 2031 (%)
12.1.1.1 Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.1.1 Overview
12.1.1.2 Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.2.1 Germany: Bioprocessing Market Breakdown, by Product
12.1.1.2.1.1 Germany: Bioprocessing Market Breakdown, by Instruments
12.1.1.2.1.1.1 Germany: Bioprocessing Market Breakdown, by Bioreactors
12.1.1.2.1.1.2 Germany: Bioprocessing Market Breakdown, by Chromatography Systems
12.1.1.2.1.2 Germany: Bioprocessing Market Breakdown, by Consumables & Accessories
12.1.1.2.2 Germany: Bioprocessing Market Breakdown, by Scale of Operation
12.1.1.2.3 Germany: Bioprocessing Market Breakdown, by Process
12.1.1.2.4 Germany: Bioprocessing Market Breakdown, by Application
12.1.1.2.5 Germany: Bioprocessing Market Breakdown, by End User
12.1.1.3 United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.3.1 Overview
12.1.1.4 United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.4.1 United Kingdom: Bioprocessing Market Breakdown, by Product
12.1.1.4.1.1 United Kingdom: Bioprocessing Market Breakdown, by Instruments
12.1.1.4.1.1.1 United Kingdom: Bioprocessing Market Breakdown, by Bioreactors
12.1.1.4.1.1.2 United Kingdom: Bioprocessing Market Breakdown, by Chromatography Systems
12.1.1.4.1.2 United Kingdom: Bioprocessing Market Breakdown, by Consumables & Accessories
12.1.1.4.2 United Kingdom: Bioprocessing Market Breakdown, by Scale of Operation
12.1.1.4.3 United Kingdom: Bioprocessing Market Breakdown, by Process
12.1.1.4.4 United Kingdom: Bioprocessing Market Breakdown, by Application
12.1.1.4.5 United Kingdom: Bioprocessing Market Breakdown, by End User
12.1.1.5 France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.5.1 Overview
12.1.1.6 France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.6.1 France: Bioprocessing Market Breakdown, by Product
12.1.1.6.1.1 France: Bioprocessing Market Breakdown, by Instruments
12.1.1.6.1.1.1 France: Bioprocessing Market Breakdown, by Bioreactors
12.1.1.6.1.1.2 France: Bioprocessing Market Breakdown, by Chromatography Systems
12.1.1.6.1.2 France: Bioprocessing Market Breakdown, by Consumables & Accessories
12.1.1.6.2 France: Bioprocessing Market Breakdown, by Scale of Operation
12.1.1.6.3 France: Bioprocessing Market Breakdown, by Process
12.1.1.6.4 France: Bioprocessing Market Breakdown, by Application
12.1.1.6.5 France: Bioprocessing Market Breakdown, by End User
12.1.1.7 Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.7.1 Overview
12.1.1.8 Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.8.1 Italy: Bioprocessing Market Breakdown, by Product
12.1.1.8.1.1 Italy: Bioprocessing Market Breakdown, by Instruments
12.1.1.8.1.1.1 Italy: Bioprocessing Market Breakdown, by Bioreactors
12.1.1.8.2 Italy: Bioprocessing Market Breakdown, by Chromatography Systems
12.1.1.8.2.1 Italy: Bioprocessing Market Breakdown, by Consumables & Accessories
12.1.1.8.3 Italy: Bioprocessing Market Breakdown, by Scale of Operation
12.1.1.8.4 Italy: Bioprocessing Market Breakdown, by Process
12.1.1.8.5 Italy: Bioprocessing Market Breakdown, by Application
12.1.1.8.6 Italy: Bioprocessing Market Breakdown, by End User
12.1.1.9 Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.9.1 Overview
12.1.1.10 Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.10.1 Spain: Bioprocessing Market Breakdown, by Product
12.1.1.10.1.1 Spain: Bioprocessing Market Breakdown, by Instruments
12.1.1.10.1.1.1 Spain: Bioprocessing Market Breakdown, by Bioreactors
12.1.1.10.1.1.2 Spain: Bioprocessing Market Breakdown, by Chromatography Systems
12.1.1.10.1.2 Spain: Bioprocessing Market Breakdown, by Consumables & Accessories
12.1.1.10.2 Spain: Bioprocessing Market Breakdown, by Scale of Operation
12.1.1.10.3 Spain: Bioprocessing Market Breakdown, by Process
12.1.1.10.4 Spain: Bioprocessing Market Breakdown, by Application
12.1.1.10.5 Spain: Bioprocessing Market Breakdown, by End User
12.1.1.11 Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.11.1 Overview
12.1.1.12 Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.12.1 Rest of Europe: Bioprocessing Market Breakdown, by Product
12.1.1.12.1.1 Rest of Europe: Bioprocessing Market Breakdown, by Instruments
12.1.1.12.1.1.1 Rest of Europe: Bioprocessing Market Breakdown, by Bioreactors
12.1.1.12.1.1.2 Rest of Europe: Bioprocessing Market Breakdown, by Chromatography Systems
12.1.1.12.1.2 Rest of Europe: Bioprocessing Market Breakdown, by Consumables & Accessories
12.1.1.12.2 Rest of Europe: Bioprocessing Market Breakdown, by Scale of Operation
12.1.1.12.3 Rest of Europe: Bioprocessing Market Breakdown, by Process
12.1.1.12.4 Rest of Europe: Bioprocessing Market Breakdown, by Application
12.1.1.12.5 Rest of Europe: Bioprocessing Market Breakdown, by End User
13. Industry Landscape
13.1 Overview
13.2 Growth Strategies in the Bioprocessing Market
13.3 Inorganic Growth Strategies
13.3.1 Overview
13.4 Organic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 Getinge AB
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Thermo Fisher Scientific Inc
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Sartorius AG
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Corning Inc
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Bio-Rad Laboratories Inc
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Merck KGaA
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 3M Co
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Eppendorf SE
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Repligen Corp
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Entegris Inc
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
14.11 Agilent Technologies Inc
14.11.1 Key Facts
14.11.2 Business Description
14.11.3 Products and Services
14.11.4 Financial Overview
14.11.5 SWOT Analysis
14.11.6 Key Developments
14.12 Cytiva US LLC
14.12.1 Key Facts
14.12.2 Business Description
14.12.3 Products and Services
14.12.4 Financial Overview
14.12.5 SWOT Analysis
14.12.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
?
List of Tables
Table 1. Europe Bioprocessing Market Segmentation
Table 2. List of Vendors
Table 3. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Instruments
Table 4. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Bioreactors
Table 5. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Chromatography Systems
Table 6. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Consumables & Accessories
Table 7. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 8. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 9. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 10. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 11. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 12. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 13. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 14. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 15. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 16. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 17. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 18. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 19. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 20. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 21. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 22. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 23. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 24. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 25. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 26. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 27. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 28. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 29. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 30. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 31. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 32. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 33. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 34. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 35. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 36. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 37. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 38. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 39. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 40. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 41. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 42. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 43. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 44. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 45. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 46. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 47. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 48. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 49. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 50. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 51. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 52. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 53. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 54. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 55. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 56. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 57. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 58. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 59. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 60. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 61. Recent Inorganic Growth Strategies in the Bioprocessing Market
Table 62. Recent Organic Growth Strategies in the Bioprocessing Market
Table 63. Glossary of Terms, Bioprocessing Market
?
List of Figures
Figure 1. Europe Bioprocessing Market Segmentation, by Country
Figure 2. Bioprocessing Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Bioprocessing Market Revenue (US$ Million), 2021-2031
Figure 5. Bioprocessing Market Share (%) - by Product (2023 and 2031)
Figure 6. Instruments: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 7. Consumables & Accessories: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Bioprocessing Market Share (%) - by Scale of Operation (2023 and 2031)
Figure 9. Commercial Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. Clinical Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. Bioprocessing Market Share (%) - by Process (2023 and 2031)
Figure 12. Downstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Upstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. Bioprocessing Market Share (%) - by Application (2023 and 2031)
Figure 15. Monoclonal Antibodies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Vaccines: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 17. Recombinant Protein: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. Cell & Gene Therapy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 19. Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 20. Bioprocessing Market Share (%) - by End User (2023 and 2031)
Figure 21. Biopharmaceutical Companies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 22. Contract Manufacturing Organization: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 23. Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 24. Europe: Bioprocessing Market, by Key Country - Revenue (2023) (US$ Million)
Figure 25. Europe: Bioprocessing Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 26. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 27. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 28. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 29. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 30. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 31. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 32. Growth Strategies in the Bioprocessing Market
- Getinge AB
- Thermo Fisher Scientific Inc
- Sartorius AG
- Corning Inc
- Bio-Rad Laboratories Inc
- Merck KGaA
- 3M Co
- Eppendorf SE
- Repligen Corp
- Entegris Inc
- Agilent Technologies Inc
- Cytiva US LLC.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe bioprocessing market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Europe bioprocessing market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe bioprocessing market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.